StockWatch
·
Biotechnology: Pharmaceutical Preparations
Loan & DebtJun 9, 2026, 04:36 PM

Aditxt Issues $725K+ in New Secured Convertible Notes

AI Summary

Aditxt, Inc. and its wholly-owned subsidiary, Ignite Proteomics LLC, have entered into a Note Purchase Agreement to issue new senior secured convertible notes. The aggregate principal amount includes approximately $725,000 in cash proceeds plus the outstanding obligations under existing notes, with a 35% original issue discount. Existing notes from March and April 2026 were consolidated into these new notes. Ignite Proteomics has granted a security interest in its assets, and Aditxt has pledged its equity in Ignite as collateral. The new notes mature on November 30, 2026, with an initial interest rate of 6% per annum, which can increase to 12% upon an event of default.

Key Highlights

  • Aditxt, Inc. and subsidiary Ignite Proteomics LLC issued new senior secured convertible notes.
  • Aggregate principal amount is approximately $725,000 cash plus outstanding obligations under existing notes.
  • Notes were issued with a 35% original issue discount.
  • Existing March and April notes were consolidated into the new notes.
  • Ignite Proteomics granted a security interest in its assets, and Aditxt pledged its equity in Ignite.
  • The new notes mature on November 30, 2026.
  • Interest rate is 6% per annum, increasing to 12% upon an Event of Default.